Black Rock Inc. Century Therapeutics, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IPSC
# of Institutions
69Shares Held
26.9MCall Options Held
12.1KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$2.92 Million0.87% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$1.73 Million0.18% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.35 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.28 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.7MShares$920,2850.25% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $31.8M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...